A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.

The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new biotechnology methods instead to spur innovation in the pharmaceutical ...

For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune cells from making new copies of the virus, preventing illness and ...

Draft amendments to the Drugs Rules would remove duplicate viral tests on finished plasma-derived medicines once source plasma is verified as safe, aimed at accelerating production of critical ...

Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.

While the rate of HIV in Kampala, Uganda, is more than double the national average, a recent survey of displaced youths in the city found that only ...

Nigeria has taken delivery of the first batch of 11,520 doses of Lenacapavir injection, a new twice-yearly injectable drug ...

Over 350 million people around the world use dating apps, that’s more people than the entire population of the United States. The rise of dating apps has transformed how people meet, communicate, and ...

“Medical decisions depend on accurate measurements. If a machine reads wrongly, a patient may receive unnecessary treatment ...

The World Health Organization (WHO) is issuing, for the first time, recommendations on new near-point-of-care (NPOC) ...

Katherine Stueland is the CEO of GeneDx, who led the company from a financially challenged phase to profitability in just 3 ...